首页 | 本学科首页   官方微博 | 高级检索  
     

局限期小细胞肺癌胸部放疗剂量和分割方式研究进展
引用本文:许锦彪,邱峰. 局限期小细胞肺癌胸部放疗剂量和分割方式研究进展[J]. 中华放射肿瘤学杂志, 2019, 28(6): 463-466. DOI: 10.3760/cma.j.issn.1004-4221.2019.06.015
作者姓名:许锦彪  邱峰
作者单位:赣州市肿瘤医院肿瘤科 341000;南昌大学第一附属医院肿瘤科 330006
摘    要:目前手术、全身化疗、胸部放疗及预防性脑照射的综合治疗已成为局限期小细胞肺癌的治疗共识。近几十年,药物治疗没有明显突破。在放疗方面,放疗加入的时机、靶区范围、剂量分割方式,以及预防性脑照射等是研究的热点问题。本文对局限期小细胞肺癌胸部放疗剂量和分割方式的研究进展展开简要分析。

关 键 词:肺肿瘤/放射疗法  剂量分割  研究进展  
收稿时间:2018-03-28

Research progress on dosage and segmentation of thoracic radiotherapy for limited-stage small cell lung cancer
Xu Jinbiao,Qiu Feng. Research progress on dosage and segmentation of thoracic radiotherapy for limited-stage small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2019, 28(6): 463-466. DOI: 10.3760/cma.j.issn.1004-4221.2019.06.015
Authors:Xu Jinbiao  Qiu Feng
Affiliation:Department of Oncology,Ganzhou Cancer Hospital,Ganzhou 341000,China;Department of Oncology,First Affiliated Hospital of Nanchang University,Nanchang 330006,Chian
Abstract:At present, surgery, systemic chemotherapy, thoracic radiotherapy and prophylactic cranial irradiation have been widely recognized to treat the limited-stage small cell lung cancer. In recent decades, no significant breakthrough has been reached in drug therapy. In the field of radiotherapy, the timing, target volume, mode of dose fractionation and prophylactic cranial irradiation are the hot issues. In this article, the research progress on the dose and the mode of dose fractionation for limited-stage small cell lung cancer was briefly analyzed.
Keywords:Lung neoplasms/radiotherapy  Dosage and segmentation  Research progress  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号